Boerhavia diffusa · Spreading hogweed · Punarnava root
300–500 mg root extract · vegan · gluten-free · 60 caps
Affiliate link · we earn from qualifying purchases. No paid placements.
Punarnava is the root of Boerhavia diffusa, a trailing herb used across Ayurveda, Siddha, and Unani traditions for kidney support, fluid balance, and liver health. The name translates to 'that which renews the body,' reflecting its Rasayana classification.
The root contains rotenoids (boeravinones), alkaloids (punarnavine), flavonoids, and lignans. In animal models, these constituents have shown diuretic, antihyperglycemic, antihyperlipidemic, and hepatoprotective effects. Boeravinone B and punarnavine are considered key marker compounds.
People seeking traditional Ayurvedic support for kidney function, fluid retention, or liver wellness. Often used in formulations for edema and as a general Rasayana tonic.
Avoid during pregnancy and breastfeeding. Use caution with diuretic medications or if you have existing kidney disease without medical supervision.
✓ Morning dosing supports diuretic use; evening dosing aligns with traditional tonic practice.
✓ Morning dosing supports diuretic use; evening dosing aligns with traditional tonic practice.
✓ Taking after meals may reduce gastrointestinal discomfort.
The root contains rotenoids (boeravinones), alkaloids (punarnavine), flavonoids, and lignans.
Each bar = one cited trial. Effect varies by methodology, dose, and population.
Pre-diabetic cohort (n≈80)
Target HbA1c <6.5% for pre-diabetes management.
see study
→ Review summarized antidiabetic, anti-inflammatory, hepatoprotective, and nephroprotective preclinical evidence.
see study
→ Aqueous leaf extract reduced serum and tissue cholesterol, free fatty acids, phospholipids, and triglycerides in diabetic rats.
see study
→ Leaf extract significantly decreased blood glucose and glycosylated hemoglobin while increasing plasma insulin in diabetic rats.
C · Preclinical evidence (rodent and in vitro) is substantial for antidiabetic, hepatoprotective, and diuretic effects. Human RCTs are sparse and methodologically limited.
A plain-English read of the literature behind this supplement. Not a clinical recommendation.
Key citations: PMID 24949473, PMID 15671692, PMID 15036478
How to use Punarnava specifically for fluid retention — the right dose, timing, blood markers to track, and how to know if it is working.
A clinical evidence review of Punarnava — RCT data, effect sizes, evidence grade, and what the numbers mean for your specific situation.
Everything you need to know about Punarnava — mechanism, dose, safety, buying guide for India, and what the research actually says.
SacredBod's longer take on Punarnava — context the structured blocks above don't capture.
Punarnava — literally “that which renews the body” — is one of the most widely used kidney and liver tonics in Ayurvedic medicine. The trailing herb Boerhavia diffusa grows across the Indian subcontinent and has been documented in classical texts for edema, urinary disorders, and as a Rasayana for general rejuvenation. In modern supplement form it is marketed for detox, kidney support, and metabolic health, often as standalone capsules or as part of polyherbal formulations.
The pharmacological interest in punarnava centers on its rotenoids (boeravinones A–J), the alkaloid punarnavine, and a spectrum of flavonoids and lignans. A 2014 comprehensive review catalogued preclinical studies demonstrating antidiabetic, anti-inflammatory, hepatoprotective, nephroprotective, and immunomodulatory activities. Two 2004 rodent studies from the same research group added metabolic detail: an aqueous leaf extract reduced serum and tissue lipids — cholesterol, triglycerides, free fatty acids, and phospholipids — in alloxan-diabetic rats, and a parallel study showed significant reductions in blood glucose and glycosylated hemoglobin alongside increased plasma insulin. The extract also favorably altered hepatic enzyme activity, increasing hexokinase while decreasing glucose-6-phosphatase and fructose-1,6-bisphosphatase.
These findings are consistent and mechanistically plausible, but they are also entirely preclinical. The human evidence base for punarnava is thin. Small, often uncontrolled Indian clinical trials have explored its diuretic and hepatoprotective potential, but none meet modern standards for randomization, blinding, or adequate sample size. The Cochrane-level evidence required to endorse punarnava for any specific medical indication simply does not exist. This is not unusual for traditional Ayurvedic herbs, but it is a critical framing point for honest marketing.
Safety is generally favorable at traditional doses, though punarnava’s diuretic activity means it should not be combined with prescription diuretics without medical oversight. Pregnancy and breastfeeding are contraindicated due to lack of safety data. As with many Ayurvedic botanicals, heavy metal contamination is a documented risk in poorly regulated products; third-party testing for lead, arsenic, cadmium, and mercury is essential.
For consumers interested in Ayurvedic metabolic and kidney support, punarnava offers a historically validated option with robust preclinical pharmacology. It should be approached as a traditional tonic rather than a proven therapeutic intervention, with realistic expectations and careful attention to product quality.
Peptides are physician-only. Tell us a bit and we'll route you to the right specialist.
